Key Findings:  Cannabis may improve clinical symptoms but has not demonstrated any improvement in disease activity in IBD.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  Canada
Year of Pub:  2019
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Not Applicable
Citation:  Picardo S, et al. Insights into the role of cannabis in the management of inflammatory bowel disease. Therap Adv Gastroenterol. 2019; 12:1756284819870977. doi: 10.1177/1756284819870977
Authors:  Picardo S, Kaplan GG, Sharkey KA, Seow CH